Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063217
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $6.00K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+105$2.69+$282.45171,774Direct
Oct 4, 2021Common StockPPurchaseAcquired+105$2.87+$301.35171,879Direct
Oct 5, 2021Common StockPPurchaseAcquired+105$2.82+$296.1171,984Direct
Oct 6, 2021Common StockPPurchaseAcquired+105$2.76+$289.8172,089Direct
Oct 7, 2021Common StockPPurchaseAcquired+105$2.76+$289.8172,194Direct
Oct 8, 2021Common StockPPurchaseAcquired+105$2.84+$298.2172,299Direct
Oct 11, 2021Common StockPPurchaseAcquired+105$2.73+$286.65172,404Direct
Oct 12, 2021Common StockPPurchaseAcquired+105$2.71+$284.55172,509Direct
Oct 13, 2021Common StockPPurchaseAcquired+105$2.71+$284.55172,614Direct
Oct 14, 2021Common StockPPurchaseAcquired+105$2.81+$295.05172,719Direct
Oct 15, 2021Common StockPPurchaseAcquired+105$2.76+$289.8172,824Direct
Oct 18, 2021Common StockPPurchaseAcquired+105$2.75+$288.75172,929Direct
Oct 19, 2021Common StockPPurchaseAcquired+105$2.76+$289.8173,034Direct
Oct 20, 2021Common StockPPurchaseAcquired+105$2.63+$276.15173,139Direct
Oct 21, 2021Common StockPPurchaseAcquired+105$2.65+$278.25173,244Direct
Oct 22, 2021Common StockPPurchaseAcquired+105$2.66+$279.3173,349Direct
Oct 25, 2021Common StockPPurchaseAcquired+105$2.64+$277.2173,454Direct
Oct 26, 2021Common StockPPurchaseAcquired+105$2.64+$277.2173,559Direct
Oct 27, 2021Common StockPPurchaseAcquired+105$2.61+$274.05173,664Direct
Oct 28, 2021Common StockPPurchaseAcquired+105$2.61+$274.05173,769Direct
Oct 29, 2021Common StockPPurchaseAcquired+105$2.72+$285.6173,874Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)